Dow EMEAI 1 — Revenue increased by 7.8% to $3.18B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.7%, from $3.27B to $3.18B. Over 3 years (FY 2022 to FY 2025), EMEAI 1 — Revenue shows a downward trend with a -13.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests strong regional demand or successful market penetration, while a decrease may indicate economic slowdowns, competitive pressure, or supply chain disruptions in these specific geographies.
This metric represents the total net sales generated by the company's operations within the Europe, Middle East, Africa,...
Comparable to regional revenue reporting by other global chemical or industrial conglomerates, often benchmarked against regional GDP growth and local industrial production indices.
dow_segment_emeai_1_revenues| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.10B | $5.23B | $5.51B | $5.68B | $4.63B | $3.81B | $4.05B | $3.77B | $3.40B | $3.31B | $3.48B | $3.57B | $3.57B | $3.33B | $3.27B | $3.27B | $3.09B | $2.95B | $3.18B |
| QoQ Change | — | +2.5% | +5.4% | +3.0% | -18.4% | -17.8% | +6.4% | -6.9% | -10.0% | -2.5% | +5.2% | +2.5% | -0.1% | -6.6% | -1.8% | -0.1% | -5.6% | -4.4% | +7.8% |
| YoY Change | — | — | — | +11.3% | -11.4% | — | -26.5% | -33.5% | -26.7% | -13.0% | -14.0% | -5.4% | +5.0% | +0.7% | -6.0% | -8.4% | -13.4% | -11.4% | -2.7% |